SH-NOMEN Chairman Attends G60 Corridor AI - Synthetic Biology Conference in Shanghai

On May 9, the G60 Sci - tech Innovation Corridor AI - enhanced synthetic biology factor - matching meeting, jointly organized by 

the G60 Corridor Joint Meeting Office, Songjiang District's Sci - tech Innovation Development Office, Sunano Pharma Tech 

(Shanghai) Co., Ltd., and SH-NOMEN Pharmaceutical Equipment (Shanghai) Co., Ltd., was held in Songjiang, Shanghai. 

Nearly 400 representatives from leading enterprises and experts from professional institutions attended to discuss the 

integration of AI and synthetic biology.

Government - Enterprise Collaboration to Build a New Industrial Ecosystem

In his address, Bao Chunli, former president of the Chinese Academy of Sciences (CAS), highlighted that the in - depth integration 

of AI and synthetic biology is reshaping the fundamental logic of life sciences, with the G60 Sci - tech Innovation Corridor serving 

as a key hub for technological transformation. Liu Fusheng, district committee member and deputy district head of Songjiang, 

noted that within the district's "2 + 7" modern industrial system, the life - health industry has established an innovation matrix 

led by top enterprises like Fosun Pharma, Sunano Pharma Tech, and SH-NOMEN Pharmaceutical Equipment. The district is 

home to over 3,000 biomedical companies and holds the second - largest number of medical device licenses in the city, providing 

fertile ground for the industrialization of AI - synthetic biology.

SH-NOMEN's Involvement in Technological Breakthroughs

As a benchmark enterprise in the intelligent transformation of pharmaceutical equipment, SH-NOMEN actively participated in 

the event. Its chairman, Li Manrong, attended and joined experts such as Li Yin, chief scientist of the State - backed investment 

group, and Zhang Dawei, deputy head of the Tianjin Institute of Industrial Biotechnology of the CAS, to discuss "AI - synthetic 

biology from molecular design to industrial application." Li emphasized that intelligent upgrades of aseptic valves are crucial for 

bridging AI design and production. SH-NOMEN's innovation in modular aseptic valves and OEB5 - sealed αβ aseptic valves 

integrated with AI control systems has boosted synthetic biology R & D efficiency, prompting in - depth thinking on collaborative 

development between equipment manufacturing and technological transformation.

Upgraded Collaborative Innovation among Academia, Industry, and Research

During the conference, authoritative experts like Ding Huiling, president of ShanghaiTech University, and Zhang Xian'an, dean of 

the Shenzhen Institute of Advanced Technology's School of Synthetic Biology, shared cutting - edge research. SH-NOMEN's 

soon - to - be - launched self - developed AI - aseptic valve drew attention in the technology exhibition area. Featuring 

closed - loop intelligent control from remote switching to production parameter optimization, the valve helps reduce costs and 

improve efficiency for Yangtze River Delta synthetic biology enterprises.

The Songjiang District Science and Technology Commission announced policies to support the biopharmaceutical industry, 

particularly for tech - excellent enterprises like Sunano and SH-NOMEN. Songjiang is now forming a synthetic biology cluster 

supported by Sunano Pharma and SH-NOMEN and led by Fosun Pharma, accelerating its global - leading biopharmaceutical 

innovation hub.

G60 Corridor Sets Industrial Collaboration Example

A G60 Corridor Joint Office official stated that the event, with deep participation from Sunano Pharma Tech and SH-NOMEN, 

strengthened the integrated innovation ecosystem of "government, industry, academia, research, finance, application, and 

services." Future efforts will concentrate on key areas like synthetic biology equipment manufacturing and AI algorithm 

development. By establishing industrial collaboration innovation centers via enterprises like Sunano and SH-NOMEN, more 

laboratory achievements will be converted into production - line momentum through the G60 Corridor, providing a "G60 

solution" for the nation's synthetic biology industrialization.

Image source: G60 Joint Office.